vs
Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and AVIENT CORP (AVNT). Click either name above to swap in a different company.
Acadia Healthcare Company, Inc. is the larger business by last-quarter revenue ($829.0M vs $760.6M, roughly 1.1× AVIENT CORP). AVIENT CORP runs the higher net margin — 2.2% vs 0.5%, a 1.7% gap on every dollar of revenue. On growth, Acadia Healthcare Company, Inc. posted the faster year-over-year revenue change (7.5% vs 1.9%). Over the past eight quarters, Acadia Healthcare Company, Inc.'s revenue compounded faster (2.0% CAGR vs -4.2%).
Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.
Avient Corporation is a global materials solutions company headquartered in Avon Lake, Ohio, United States, employing approximately 9,000 people worldwide. Its products include colorants, advanced composites, functional additives and engineered materials.
ACHC vs AVNT — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $829.0M | $760.6M |
| Net Profit | $4.5M | $16.9M |
| Gross Margin | — | 30.2% |
| Operating Margin | — | 5.2% |
| Net Margin | 0.5% | 2.2% |
| Revenue YoY | 7.5% | 1.9% |
| Net Profit YoY | -50.8% | -65.0% |
| EPS (diluted) | $0.05 | $0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $829.0M | — | ||
| Q4 25 | $821.5M | $760.6M | ||
| Q3 25 | $851.6M | $806.5M | ||
| Q2 25 | $869.2M | $866.5M | ||
| Q1 25 | $770.5M | $826.6M | ||
| Q4 24 | $774.2M | $746.5M | ||
| Q3 24 | $815.6M | $815.2M | ||
| Q2 24 | $796.0M | $849.7M |
| Q1 26 | $4.5M | — | ||
| Q4 25 | $-1.2B | $16.9M | ||
| Q3 25 | $36.2M | $32.6M | ||
| Q2 25 | $30.1M | $52.6M | ||
| Q1 25 | $8.4M | $-20.2M | ||
| Q4 24 | $32.6M | $48.3M | ||
| Q3 24 | $68.1M | $38.2M | ||
| Q2 24 | $78.5M | $33.6M |
| Q1 26 | — | — | ||
| Q4 25 | — | 30.2% | ||
| Q3 25 | — | 30.4% | ||
| Q2 25 | — | 32.1% | ||
| Q1 25 | — | 31.8% | ||
| Q4 24 | — | 34.8% | ||
| Q3 24 | — | 32.1% | ||
| Q2 24 | — | 30.3% |
| Q1 26 | — | — | ||
| Q4 25 | -142.4% | 5.2% | ||
| Q3 25 | 4.7% | 8.3% | ||
| Q2 25 | 5.8% | 11.1% | ||
| Q1 25 | 1.7% | 0.1% | ||
| Q4 24 | 4.9% | 11.5% | ||
| Q3 24 | 12.1% | 9.5% | ||
| Q2 24 | 13.4% | 8.5% |
| Q1 26 | 0.5% | — | ||
| Q4 25 | -143.3% | 2.2% | ||
| Q3 25 | 4.3% | 4.0% | ||
| Q2 25 | 3.5% | 6.1% | ||
| Q1 25 | 1.1% | -2.4% | ||
| Q4 24 | 4.2% | 6.5% | ||
| Q3 24 | 8.4% | 4.7% | ||
| Q2 24 | 9.9% | 4.0% |
| Q1 26 | $0.05 | — | ||
| Q4 25 | $-12.98 | $0.18 | ||
| Q3 25 | $0.40 | $0.36 | ||
| Q2 25 | $0.33 | $0.57 | ||
| Q1 25 | $0.09 | $-0.22 | ||
| Q4 24 | $0.36 | $0.53 | ||
| Q3 24 | $0.74 | $0.41 | ||
| Q2 24 | $0.85 | $0.36 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $158.5M | — |
| Total DebtLower is stronger | $2.5B | $1.9B |
| Stockholders' EquityBook value | $2.0B | $2.4B |
| Total Assets | $5.5B | $6.0B |
| Debt / EquityLower = less leverage | 1.29× | 0.81× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $158.5M | — | ||
| Q4 25 | $133.2M | — | ||
| Q3 25 | $118.7M | — | ||
| Q2 25 | $131.4M | — | ||
| Q1 25 | $91.2M | — | ||
| Q4 24 | $76.3M | — | ||
| Q3 24 | $82.1M | — | ||
| Q2 24 | $77.2M | — |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $2.5B | $1.9B | ||
| Q3 25 | $2.3B | $2.0B | ||
| Q2 25 | $2.3B | $2.0B | ||
| Q1 25 | $2.2B | $2.1B | ||
| Q4 24 | $2.0B | $2.1B | ||
| Q3 24 | $1.9B | $2.1B | ||
| Q2 24 | $1.8B | $2.1B |
| Q1 26 | $2.0B | — | ||
| Q4 25 | $1.9B | $2.4B | ||
| Q3 25 | $3.1B | $2.4B | ||
| Q2 25 | $3.1B | $2.4B | ||
| Q1 25 | $3.0B | $2.3B | ||
| Q4 24 | $3.1B | $2.3B | ||
| Q3 24 | $3.0B | $2.4B | ||
| Q2 24 | $3.0B | $2.3B |
| Q1 26 | $5.5B | — | ||
| Q4 25 | $5.5B | $6.0B | ||
| Q3 25 | $6.4B | $6.1B | ||
| Q2 25 | $6.3B | $6.1B | ||
| Q1 25 | $6.1B | $5.8B | ||
| Q4 24 | $6.0B | $5.8B | ||
| Q3 24 | $5.9B | $6.0B | ||
| Q2 24 | $5.7B | $5.9B |
| Q1 26 | 1.29× | — | ||
| Q4 25 | 1.28× | 0.81× | ||
| Q3 25 | 0.74× | 0.83× | ||
| Q2 25 | 0.74× | 0.86× | ||
| Q1 25 | 0.72× | 0.90× | ||
| Q4 24 | 0.64× | 0.89× | ||
| Q3 24 | 0.62× | 0.88× | ||
| Q2 24 | 0.62× | 0.90× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $61.5M | $167.8M |
| Free Cash FlowOCF − Capex | — | $125.4M |
| FCF MarginFCF / Revenue | — | 16.5% |
| Capex IntensityCapex / Revenue | — | 5.6% |
| Cash ConversionOCF / Net Profit | 13.78× | 9.93× |
| TTM Free Cash FlowTrailing 4 quarters | — | $195.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $61.5M | — | ||
| Q4 25 | $-86.3M | $167.8M | ||
| Q3 25 | $73.2M | $72.1M | ||
| Q2 25 | $133.5M | $112.8M | ||
| Q1 25 | $11.5M | $-51.1M | ||
| Q4 24 | $116.7M | $122.6M | ||
| Q3 24 | $163.1M | $71.1M | ||
| Q2 24 | $171.1M | $105.9M |
| Q1 26 | — | — | ||
| Q4 25 | $-179.5M | $125.4M | ||
| Q3 25 | $-63.0M | $47.4M | ||
| Q2 25 | $-34.2M | $85.8M | ||
| Q1 25 | $-163.2M | $-63.6M | ||
| Q4 24 | $-86.8M | $81.5M | ||
| Q3 24 | $-27.1M | $46.1M | ||
| Q2 24 | $16.9M | $74.5M |
| Q1 26 | — | — | ||
| Q4 25 | -21.8% | 16.5% | ||
| Q3 25 | -7.4% | 5.9% | ||
| Q2 25 | -3.9% | 9.9% | ||
| Q1 25 | -21.2% | -7.7% | ||
| Q4 24 | -11.2% | 10.9% | ||
| Q3 24 | -3.3% | 5.7% | ||
| Q2 24 | 2.1% | 8.8% |
| Q1 26 | — | — | ||
| Q4 25 | 11.3% | 5.6% | ||
| Q3 25 | 16.0% | 3.1% | ||
| Q2 25 | 19.3% | 3.1% | ||
| Q1 25 | 22.7% | 1.5% | ||
| Q4 24 | 26.3% | 5.5% | ||
| Q3 24 | 23.3% | 3.1% | ||
| Q2 24 | 19.4% | 3.7% |
| Q1 26 | 13.78× | — | ||
| Q4 25 | — | 9.93× | ||
| Q3 25 | 2.02× | 2.21× | ||
| Q2 25 | 4.43× | 2.14× | ||
| Q1 25 | 1.37× | — | ||
| Q4 24 | 3.58× | 2.54× | ||
| Q3 24 | 2.39× | 1.86× | ||
| Q2 24 | 2.18× | 3.15× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ACHC
| Acute Inpatient Psychiatric Facilities | $471.0M | 57% |
| Other | $140.0M | 17% |
| Specialty Treatment Facilities | $128.0M | 15% |
| Residential Treatment Facilities | $90.0M | 11% |
AVNT
| Color Additives And Inks | $466.0M | 61% |
| Specialty Engineered Materials | $295.5M | 39% |
